165 related articles for article (PubMed ID: 17545478)
21. Protective effects of the delta opioid peptide [D-Ala2, D-Leu5]enkephalin in an ex vivo model of ischemia/reperfusion in brain slices.
Zheng YJ; Wang XR; Chen HZ; Wu XJ; Zhao YH; Su DS
CNS Neurosci Ther; 2012 Sep; 18(9):762-6. PubMed ID: 22943142
[TBL] [Abstract][Full Text] [Related]
22. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.
Hausenloy DJ; Tsang A; Mocanu MM; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H971-6. PubMed ID: 15358610
[TBL] [Abstract][Full Text] [Related]
23. delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway.
Zhao M; Wang HX; Yang J; Su YH; Su RJ; Wong TM
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):97-102. PubMed ID: 18047635
[TBL] [Abstract][Full Text] [Related]
24. Essential activation of PKC-delta in opioid-initiated cardioprotection.
Fryer RM; Wang Y; Hsu AK; Gross GJ
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1346-53. PubMed ID: 11179083
[TBL] [Abstract][Full Text] [Related]
25. Alpha 2-Adrenergic Receptor Agonist Brimonidine Stimulates ERK1/2 and AKT Signaling via Transactivation of EGF Receptors in the Human MIO-M1 Müller Cell Line.
Harun-Or-Rashid M; Hallböök F
Curr Eye Res; 2019 Jan; 44(1):34-45. PubMed ID: 30198788
[TBL] [Abstract][Full Text] [Related]
26. Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning.
Williams-Pritchard G; Knight M; Hoe LS; Headrick JP; Peart JN
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2161-8. PubMed ID: 21460200
[TBL] [Abstract][Full Text] [Related]
27. HL-1 myocytes exhibit PKC and K(ATP) channel-dependent delta opioid preconditioning.
Seymour EM; Wu SY; Kovach MA; Romano MA; Traynor JR; Claycomb WC; Bolling SF
J Surg Res; 2003 Oct; 114(2):187-94. PubMed ID: 14559445
[TBL] [Abstract][Full Text] [Related]
28. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia.
Iwata M; Inoue S; Kawaguchi M; Nakamura M; Konishi N; Furuya H
Br J Anaesth; 2007 Oct; 99(4):538-46. PubMed ID: 17704092
[TBL] [Abstract][Full Text] [Related]
29. DADLE enhances viability and anti-inflammatory effect of human MSCs subjected to 'serum free' apoptotic condition in part via the DOR/PI3K/AKT pathway.
Reddy LVK; Sen D
Life Sci; 2017 Dec; 191():195-204. PubMed ID: 29054455
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism.
Eisinger DA; Ammer H
Mol Pharmacol; 2011 Feb; 79(2):326-35. PubMed ID: 21078885
[TBL] [Abstract][Full Text] [Related]
31. Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8.
Methner C; Donat U; Felix SB; Krieg T
Acta Physiol (Oxf); 2009 Dec; 197(4):265-71. PubMed ID: 19583703
[TBL] [Abstract][Full Text] [Related]
32. Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway.
Wang Z; Tang B; Tang F; Li Y; Zhang G; Zhong L; Dong C; He S
Mol Med Rep; 2015 Sep; 12(3):4079-4088. PubMed ID: 26126577
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of activating transcription factor in murine splenocytes through delta opioid receptors.
Shahabi NA; McAllen K; Sharp BM
Cell Immunol; 2003 Feb; 221(2):122-7. PubMed ID: 12747953
[TBL] [Abstract][Full Text] [Related]
34. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
Tang CW; Feng WM; Du HM; Bao Y; Zhu M
Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
[TBL] [Abstract][Full Text] [Related]
35. [Ischemic preconditioning of the heart can be simulated by pharmacologic hibernation enkephalins].
Karck M; Tanaka S; Oeltgen P; Su TS; Bolling SF; Haverich A
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):1-6. PubMed ID: 14518200
[TBL] [Abstract][Full Text] [Related]
36. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases.
Kramer HK; Onoprishvili I; Andria ML; Hanna K; Sheinkman K; Haddad LB; Simon EJ
BMC Pharmacol; 2002; 2():5. PubMed ID: 11897012
[TBL] [Abstract][Full Text] [Related]
37. Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway.
Philipp S; Critz SD; Cui L; Solodushko V; Cohen MV; Downey JM
Basic Res Cardiol; 2006 Mar; 101(2):159-67. PubMed ID: 16283591
[TBL] [Abstract][Full Text] [Related]
38. Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2.
Zhang LS; Wang YJ; Ju YY; Zan GY; Xu C; Hong MH; Wang YH; Chi ZQ; Liu JG
Br J Pharmacol; 2015 Oct; 172(20):4847-63. PubMed ID: 26211551
[TBL] [Abstract][Full Text] [Related]
39. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
40. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin in PC12 cells.
Hayashi T; Tsao LI; Su TP
Synapse; 2002 Jan; 43(1):86-94. PubMed ID: 11746737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
